Publicada por Dbspoctefa en Lunes, 2 de septiembre de 2019
Control of patients with hip or knee prostheses. It is estimated that each year, 2000 people receive hip and knee prostheses in Zaragoza and Pyrénées-Atlantiques, a number that increases every year.
The diagnosis of Wilson’s disease, a rare genetic disorder that is associated with a problem in copper metabolism. It is simple to treat but very difficult to diagnose, and can be fatal without proper treatment.
The public University of Aragon Community.
More information: www.unizar.es
The University of Zaragoza leads the project. In addition to coordinating the actions of all partners and associated entities, it will develop actions related to elemental and multi-elemental analysis, and nanoparticle detection.
Dr. Martín Resano Ezcaray
(i3A, Departamento de Química Analítica)
Dra. Esperanza García Ruiz
(i3A, Departamento de Química Analítica)
Dra. Maite Bona García
(Oficina de Proyectos Europeos)
The main public research organization of France.
More information: http://www.cnrs.fr/
CNRS participates as a partner through the IPREM (https://iprem.univ-pau.fr/fr/index.html) and is responsible for all actions related to isotopic analysis and laser ablation.
Dr. Christophe Pécheyran
(IPREM (Institut des sciences analytiques et physico chimique pour l’environnement et les matériaux) – CNRS Délégation Aquitaine)
Dr. Sylvain Bérail
(IPREM- CNRS Délégation Aquitaine)
Dr. Olivier Donard
(IPREM- CNRS Délégation Aquitaine)
María del Carmen García Poyo
(IPREM- CNRS Délégation Aquitaine)
Dra. Hélène Tabouret
(IPREM- CNRS Délégation Aquitaine)
Dra. Zoyne Pedrero
(IPREM- CNRS Délégation Aquitaine)
Caroline Angeli
(IPREM- CNRS Délégation Aquitaine)
It is the Health Research Institute of the Hospital Complex formed by the University Hospitals “Lozano Blesa University Clinical Hospital” and “Miguel Servet University Hospital” and the Primary Health Care. This Hospital complex is associated through different legal instruments with the University of Zaragoza and with the Aragon Institute of Health Sciences.
More information: http://www.iisaragon.es
IIS participates as a partner, taking care of sampling and the management of the samples, the establishment of reference values and the assessment, improvement, and application of the methods developed.
Dr. Luis Rello Varas
(Sección Bioquímica Clínica, Hospital Universitario Miguel Servet)
Dña. Elena García González
(Sección Bioquímica Clínica, Hospital Universitario Miguel Servet)
D. Sergio Cervero Benedí
(IIS)
It is a public Higher Education center, located in the General Military Academy and attached to the University of Zaragoza.
More information: http://cud.unizar.es
Dr. Aramendía will collaborate in all the scientific actions in which the personnel of the University of Zaragoza participates.
Dra. Maite Aramendía Marzo
(Área de Química y Medio Ambiente)
One of the main public Hospitals in France
More information: https://www.chu-angers.fr/
CHU Angers has a group dedicated to the study and diagnosis of Wilson’s disease.
Dra. Bénédicte Lelièvre
(Laboratoire de pharmacologie toxicologie)
We are pleased to invite you to the final day of the DBS project “Dried blood spots for minimally invasive clinical analysis and early detection of rare diseases (EFA 176/16 / DBS)” (http://dbs.unizar.es/), funded by the Interreg POCTEFA program, which will take place on November 18th, 2021 from 11:00 to 13:30. To attend the conference,…
Interview with Prof. Martín Resano to Despierta Aragón from Radio Aragón.
The European DBS project, in addition to investigating the development of less invasive clinical testing procedures, is also investigating how to diagnose Wilson’s disease. In order to have more information and better knowledgement about Cu metabolism, in addition to determining the total concentration of Cu, we also carry out the isotopic analysis of Cu. The…
